Aeglea Biotherapeutics shares owned by Fairmount Funds Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Fairmount Funds Management
from 13F filings
Historical chart of Fairmount Funds Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Fairmount Funds Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $67M | 4.0M | 16.76 |
| 2025-06-30 | $60M | 4.0M | 14.97 |
| 2025-03-31 | $65M | 4.0M | 16.14 |
| 2024-12-31 | $94M | 4.0M | 23.28 |
| 2024-09-30 | $118M | 4.0M | 29.41 |
| 2024-06-30 | $95M | 4.0M | 23.51 |
| 2024-03-31 | $14M | 378k | 37.93 |
| 2023-12-31 | $8.1M | 378k | 21.52 |
| 2023-09-30 | $4.6M | 378k | 12.25 |
More positions owned by Fairmount Funds Management
View all positions for Fairmount Funds Management